We are pleased to share the exciting news about our latest outstanding impact factor results: the new 𝗜𝗙 𝟮𝟬𝟮𝟱 𝗳𝗼𝗿 𝗔𝗴𝗶𝗻𝗴 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗮𝗻𝗱 𝗘𝘅𝗽𝗲𝗿𝗶𝗺𝗲𝗻𝘁𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗶𝘀 𝟰.𝟳 and it is 𝗿𝗮𝗻𝗸𝗲𝗱 𝟮𝟬/𝟳𝟮 (𝗤𝟮) in Geriatrics & Gerontology category.

Additionally, we are delighted to highlight ACER’s exceptional performance in terms of speed: a remarkable median of 𝗷𝘂𝘀𝘁 𝟳 𝗱𝗮𝘆𝘀 𝗳𝗿𝗼𝗺 𝘀𝘂𝗯𝗺𝗶𝘀𝘀𝗶𝗼𝗻 𝘁𝗼 𝗳𝗶𝗿𝘀𝘁 𝗱𝗲𝗰𝗶𝘀𝗶𝗼𝗻, alongside an impressive milestone in visibility, with 𝟮 𝗺𝗶𝗹𝗹𝗶𝗼𝗻 𝗱𝗼𝘄𝗻𝗹𝗼𝗮𝗱𝘀 𝗶𝗻 𝟮𝟬𝟮𝟱.
We would also like to extend our warmest and most sincere thanks for your continued cooperation and invaluable contributions to the success of ACER, which we are proud to consider 𝙩𝙝𝙚 𝙤𝙩𝙝𝙚𝙧 𝙢𝙪𝙨𝙘𝙪𝙡𝙤𝙨𝙠𝙚𝙡𝙚𝙩𝙖𝙡 𝙟𝙤𝙪𝙧𝙣𝙖𝙡.

Your dedication, passion, and hard work have been instrumental in reaching these achievements, and they are truly appreciated.
𝗖𝗼𝗻𝗴𝗿𝗮𝘁𝘂𝗹𝗮𝘁𝗶𝗼𝗻𝘀 𝘁𝗼 𝗲𝗮𝗰𝗵 𝗮𝗻𝗱 𝗲𝘃𝗲𝗿𝘆 𝗼𝗻𝗲 𝗼𝗳 𝘆𝗼𝘂 𝗼𝗻 𝘁𝗵𝗶𝘀 𝗼𝘂𝘁𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴 𝘀𝘂𝗰𝗰𝗲𝘀𝘀!

Once again, thank you for your support and commitment and feel free to reach out if you have any questions.

Warm regards,

Professor Nicola Veronese
Editor-in-Chief of ACER